CorVista System with PH Add-On vs Eko Analysis Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CorVista Health
VS
by Eko Devices

AI Verdict

Tool A is designed for rapid, non-invasive assessment of coronary artery disease and pulmonary hypertension using a dedicated diagnostic platform. Tool B, conversely, integrates with digital stethoscopes to aid clinicians in the early detection of heart murmurs and atrial fibrillation through enhanced auscultation. While both leverage AI for cardiovascular health, their distinct diagnostic targets and data acquisition methodologies make them complementary rather than directly competitive.

Choose CorVista System with PH Add-On if…

Choose CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for simultaneously assessing both coronary artery disease and pulmonary hypertension. This system is ideal when you need quick results without the need for radiation, contrast agents, or extensive patient preparation, providing a comprehensive cardiovascular snapshot within minutes.

View CorVista System with PH Add-On →

Choose Eko Analysis Software if…

Choose Eko Analysis Software if your primary need is to augment routine physical examinations with AI-powered auscultation for early detection of specific cardiovascular conditions like heart murmurs and atrial fibrillation. This tool is best suited for clinicians utilizing digital stethoscopes who want to record, visualize, and store heart sounds and ECGs, facilitating enhanced screening and potential remote monitoring capabilities.

View Eko Analysis Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CorVista System with PH Add-On Eko Analysis Software
Pricing Unknown Freemium with subscription for full features
Deployment Cloud-based, point-of-care system. Cloud-based
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CorVista System with PH Add-On

Tool A offers a non-invasive diagnostic platform that eliminates the need for radiation, contrast agents, injections, fasting, or exercise, significantly simplifying the patient experience and diagnostic process. Its rapid, point-of-care results further enhance usability for both patients and clinicians by streamlining workflow.

Clinical Value

CorVista System with PH Add-On

Both tools are FDA-cleared and provide valuable diagnostic capabilities. However, Tool A addresses the rapid assessment of complex and serious conditions like coronary artery disease and pulmonary hypertension with a novel non-invasive approach, potentially reducing the need for more invasive procedures. Tool B, while valuable for early detection of murmurs and AFib, primarily augments a traditional physical examination.

Pricing & Value

Eko Analysis Software

Tool B offers a transparent freemium model with subscription options for full features, providing clear pricing and a lower barrier to entry for individual clinicians or smaller practices. Tool A's 'contact for pricing' model suggests a higher, enterprise-level investment, which lacks the same accessibility and transparency.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, HIPAA compliant, and having Business Associate Agreements (BAAs). Tool A's platform approach with modular add-ons is well-suited for integration into hospital diagnostic pathways, while Tool B offers secure cloud storage and dedicated enterprise support for its SENSORA platform, indicating robust capabilities for large-scale deployment.

Innovation

CorVista System with PH Add-On

Tool A presents a more significant innovation by offering a completely non-invasive, point-of-care AI diagnostic platform for complex cardiovascular diseases, potentially replacing more invasive or resource-intensive diagnostic methods. Tool B, while innovative in augmenting digital stethoscopes with AI for early detection, builds upon an existing diagnostic tool rather than introducing a new diagnostic modality.

Support & Docs

Eko Analysis Software

Tool B provides a significantly more comprehensive and publicly accessible support and documentation ecosystem, including a dedicated Help Center with user manuals, FAQs, troubleshooting guides, and multiple contact options. Tool A's support appears to be more direct and enterprise-focused, with less publicly available documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CorVista System with PH Add-On Eko Analysis Software
Product Name CorVista System with PH Add-On Eko Analysis Software
Company Analytics for Life Eko Devices
Primary Diagnoses Supported Coronary artery disease and pulmonary hypertension Heart murmurs and atrial fibrillation
Data Input Method Non-invasive analysis of cardiac and hemodynamic signals (no radiation, contrast agents, injections, fasting, or exercise required) Integrates with Eko's digital stethoscopes and mobile app for wireless auscultation and ECGs
Result Output/Access Rapid results available within minutes via secure web portal Recordings, patient profiles, and PDF reports (with subscription); secure cloud-based storage of recordings

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and Eko Analysis Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CorVista System with PH Add-On is designed for the rapid assessment of coronary artery disease (CAD) and pulmonary hypertension (PH) using machine-learned algorithms. In contrast, the Eko Analysis Software focuses on the early detection of heart murmurs and atrial fibrillation (AFib), as well as identifying normal sinus rhythm.
The CorVista System is a non-invasive, point-of-care platform that analyzes cardiac and hemodynamic signals without requiring radiation, contrast agents, injections, fasting, or exercise. The Eko Analysis Software integrates with Eko's digital stethoscopes and a mobile app, utilizing AI to analyze heart sounds and ECGs obtained through wireless auscultation.
The CorVista System is designed to provide rapid results within minutes, with the analysis available through a secure web portal. The Eko Analysis Software provides AI-powered detection capabilities that assist clinicians in real-time during auscultation, with the ability to record, playback, and annotate heart sounds and ECGs.
The CorVista System is a point-of-care solution that involves a capture device to collect physiological signals, with results delivered via a secure web portal. The Eko Analysis Software requires integration with Eko's digital stethoscopes and a compatible mobile app for its AI-powered detection and recording features.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.